Allopurinol (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Allopurinol" in French language version.

refsWebsite

Global rank French rank

2sciencedirect.com

149^th place

80^th place

2ahajournals.org

3,608^th place

659^th place

1qmul.ac.uk

1,735^th place

168^th place

1thelancet.com

2,393^rd place

506^th place

1onlinejacc.org

low place

2,587^th place

1ijp-online.com

low place

1springer.com

274^th place

223^rd place

1jamanetwork.com

2,650^th place

689^th place

1nih.gov

4^th place

12^th place

1europa.eu

68^th place

67^th place

1aspetjournals.org

6,663^rd place

5,973^rd place

1has-sante.fr

9,562^nd place

535^th place

1doi.org

2^nd place

3^rd place

1em-consulte.com

low place

1,005^th place

1who.int

195^th place

221^st place

1researchgate.net

120^th place

178^th place

ahajournals.org

circres.ahajournals.org

(en) Ekelund UE, Harrison RW, Shokek O et al. « Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure » Circ Res. 1999;85:437-445

circ.ahajournals.org

George J, Carr E, Davies J, Belch JJ, Struthers A, High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid, Circulation, 2006;114:2508-2516

aspetjournals.org

pharmrev.aspetjournals.org

Pacher P, Nivorozhkin A, Szabó C, Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol, Pharmacol Rev, 2006;58:87-114

doi.org

dx.doi.org

Jean-Louis Schlienger, « L’histoire des tourments de la podagre (goutte) », MÉDECINE DES MALADIES MÉTABOLIQUES, vol. 8, n^o 2,‎ avril 2014, p. 230-234 (DOI 10.1016/S1957-2557(14)70747-3, lire en ligne, consulté le 28 mai 2024)

em-consulte.com

Jean-Louis Schlienger, « L’histoire des tourments de la podagre (goutte) », MÉDECINE DES MALADIES MÉTABOLIQUES, vol. 8, n^o 2,‎ avril 2014, p. 230-234 (DOI 10.1016/S1957-2557(14)70747-3, lire en ligne, consulté le 28 mai 2024)

europa.eu

ema.europa.eu

D'après l'Agence Européenne du Médicament, « PhVWP monthly report on safety concerns, guidelines and general matters » juillet 2012 - Issue number 1207

has-sante.fr

[PDF]Fiche Adenuric-CT-6315, HAS (France), juin 2009 (consultée le 6 février 2013)

ijp-online.com

Yaylacı S, Demir MV, Temiz T, Tamer A, Uslan MI, Allopurinol-induced DRESS syndrome, Indian J Pharmacol. 2012;44:412-414

jamanetwork.com

archinte.jamanetwork.com

Yang CY, Chen CH, Deng ST, Allopurinol use and risk of fatal hypersensitivity reactions, a nationwide population-based study in Taiwan, JAMA Intern Med, 2015;175:1550-1557

nih.gov

ncbi.nlm.nih.gov

(en) Somkrua R, Eickman EE, Saokaew S, Lohitnavy M, Chaiyakunapruk N. « Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis » BMC Med Genet. 2011 Sep 9;12:118 PMID 21906289

onlinejacc.org

content.onlinejacc.org

Rekhraj S, Gandy TJ, Szwejkowski BR et al. High-dose allopurinol reduces left ventricular mass in patients with ischemic heart disease, J Am Coll Cardiol, 2013;61:926-932

qmul.ac.uk

chem.qmul.ac.uk

Masse molaire calculée d’après « Atomic weights of the elements 2007 », sur www.chem.qmul.ac.uk.

researchgate.net

Dong, G., Ren, M., Wang, X., Jiang, H., Yin, X., Wang, S., ... & Feng, H. (2015). Allopurinol reduces severity of delayed neurologic sequelae in experimental carbon monoxide toxicity in rats. Neurotoxicology, 48, 171-179.

sciencedirect.com

Rajendra NS, Ireland S, George J, Belch JJ, Lang CC, Struthers AD, Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris, J Am Coll Cardiol, 2011;58:820-828
Halevy S, Ghislain PD, Mockenhaupt M et al. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel, J Am Acad Dermatol, 2008;58:25-32

springer.com

link.springer.com

Ramasamy SN, Korb-Wells CS, Kannangara DR et al. Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012, Drug Saf, 2013;36:953-980

thelancet.com

(en) Noman A, Ang DS, Ogston S, Lang CC, Struthers AD, « Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial » Lancet 2010;375:2161-2167

who.int

apps.who.int

WHO Model List of Essential Medicines, 18th list, avril 2013